Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin for Empathy in Schizophrenia
NCT00813436Phase 2Unknown
- Sponsor
- Shalvata Mental Health Center
- Start
- May 2008
- Primary completion
- Jan 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin in schizophrenia, sponsored by Shalvata Mental Health Center. Status: unknown.
02
Drugs
oxytocin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00813436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00813436.